Prof. Dr. med. Matthias Peipp

Prof. Dr. med. Matthias Peipp is a highly accomplished doctor specializing in stem cell transplantation and immunotherapy. With 32 years of experience, he has made significant contributions to the field, evident by his impressive 122 scientific publications. Dr. Peipp's career highlights include obtaining a teaching license, habilitation in stem cell transplantation and immunotherapy, and receiving a prestigious Hensel Prize for his work. He currently manages the Department of antibody-based immunotherapy at the University Hospital Schleswig-Holstein Kiel (UKSH) in Germany. Dr. Peipp's expertise lies in developing and engineering potent antibody-based treatments for various diseases, including cancer. His research focuses on enhancing immune effector functions and finding innovative ways to target specific molecules or receptors associated with different types of tumors. His work has shown promising results in preclinical models, particularly in pediatric T-cell acute lymphoblastic leukemia and multiple myeloma. Furthermore, he has published studies on combining antibody therapies with other drugs to improve treatment efficacy. Prof. Dr. med. Matthias Peipp's extensive knowledge, experience, and dedication to advancing immunotherapy make him a highly respected and sought-after doctor in his field. His groundbreaking research and innovative treatment approaches have the potential to revolutionize cancer therapy and improve patient outcomes.